Takeda And Enterome To Jointly Mine The Microbiome
This article was originally published in PharmAsia News
Executive Summary
In a deal that further expands its credentials, French company Enterome has inked an alliance with Japan's Takeda to conduct research and develop novel therapeutics aimed at microbiome targets thought to play crucial roles in gastrointestinal disorders.